Stéphane Dedieu Selected Research

Stéphane Dedieu Research Topics

Disease

22	Neoplasms (Cancer) 02/2022 - 01/2005
4	Colonic Neoplasms (Colon Cancer) 02/2022 - 01/2016
3	Adenocarcinoma 02/2022 - 01/2016
3	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 01/2017
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2020
2	Glioma (Gliomas) 11/2021 - 03/2021
2	Glioblastoma (Glioblastoma Multiforme) 03/2021 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2016
2	Neuroblastoma 04/2019 - 01/2017
2	Melanoma (Melanoma, Malignant) 01/2017 - 10/2016
2	Experimental Melanoma 01/2017 - 10/2016
1	Neoplasm Metastasis (Metastasis) 02/2022
1	Ovarian Neoplasms (Ovarian Cancer) 10/2021
1	Thrombosis (Thrombus) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Carcinogenesis 01/2020
1	Disease Progression 01/2017
1	Ischemia 01/2016
1	Necrosis 01/2016
1	Anastomotic Leak 01/2016
1	Brain Neoplasms (Brain Tumor) 01/2015
1	Hemorrhage 08/2009
1	Skin Diseases (Skin Disease) 01/2005
1	Acne Vulgaris 01/2005
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2005

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 11/2021 - 04/2008
5	CollagenIBA 02/2022 - 01/2017
5	Peptide Hydrolases (Proteases)FDA Link 10/2021 - 04/2008
5	TAX2 peptideIBA 04/2019 - 07/2015
4	Thrombospondin 1IBA 10/2021 - 01/2015
4	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 02/2018 - 05/2008
2	antineoplaston A10 (A 10)IBA 02/2022 - 02/2018
2	AnnexinsIBA 02/2022 - 02/2018
2	Biomarkers (Surrogate Marker)IBA 02/2022 - 02/2018
2	Messenger RNA (mRNA)IBA 02/2022 - 02/2018
2	Small Interfering RNA (siRNA)IBA 11/2021 - 07/2010
2	LDL Receptors (LDL Receptor)IBA 11/2021 - 01/2020
2	Gefitinib (Iressa)FDA Link 11/2021 - 03/2021
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2021 - 01/2020
2	IntegrinsIBA 03/2021 - 10/2017
2	Collagen Type I (Type I Collagen)IBA 01/2020 - 01/2017
2	ThrombospondinsIBA 04/2019 - 01/2017
2	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 08/2009
1	Discoidin Domain Receptor 1IBA 02/2022
1	Indicators and Reagents (Reagents)IBA 02/2022
1	CalpainIBA 01/2022
1	TalinIBA 01/2022
1	Monomeric GTP-Binding ProteinsIBA 11/2021
1	Mutant Proteins (Protein, Mutant)IBA 11/2021
1	Dynamin IIIBA 11/2021
1	ProteomeIBA 10/2021
1	PlasminogenIBA 10/2021
1	Fibrinolysin FDA Link 10/2021
1	Tyrosine Kinase InhibitorsIBA 03/2021
1	Integrin alpha5IBA 03/2021
1	Integrin alpha5beta1IBA 03/2021
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2021
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	Cell Surface ReceptorsIBA 01/2020
1	EnzymesIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2017
1	Proteoglycans (Proteoglycan)IBA 01/2017
1	LumicanIBA 01/2017
1	Therapeutic UsesIBA 10/2016
1	CholesterolIBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	Caspase 3 (Caspase-3)IBA 01/2016
1	Angiogenesis InhibitorsIBA 01/2015
1	Glycoproteins (Glycoprotein)IBA 01/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2015
1	Cytotoxins (Cytolysins)IBA 01/2015
1	Scavenger Receptors (Scavenger Receptor)IBA 05/2008
1	RetinoidsIBA 01/2005

Therapy/Procedure

3	Therapeutics 10/2021 - 01/2017
2	Lasers (Laser) 02/2022 - 02/2018
1	Drug Therapy (Chemotherapy) 01/2017
1	Colectomy 01/2016